SalioGen Therapeutics

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Cycle Offers $466m For Vanda, Which Tur

Having played such a crucial role for nearly three years in addressing the global COVID-19 pandemic, the pharma and biotech sectors are enjoying a return to something approaching normality. Neverthele

Biopharmaceutical company venture capital fundraising in 2021 broke the record set in 2020 back in the third quarter and now that the year is over, Pitchbook and the National Venture Capital Associati

The world of cell, gene and RNA therapy, which at one time may have seemed like a thing of fiction, is not only reality, but a reality that is growing at speed. With nearly 3,500 therapies in preclini